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Objective—To develop and begin to evaluate a new measure of the centrality of pain in patients’
lives.
Design—Cross-sectional survey and cognitive interviews.
Setting—Academic general internal medicine clinic.
Patients—65 adult internal medicine patients with chronic non-malignant pain (CNMP).
Outcome measures—We assessed content validity and clarity of the 10-item Centrality of Pain
Scale (COPS) by soliciting feedback from chronic pain experts and by conducting cognitive
interviews with patients with CNMP. We assessed internal consistency reliability using
Cronbach’s alpha. We assessed construct validity by comparing the COPS with other measures of
chronic pain morbidity including pain severity, depression, anxiety, physical and mental health
function, PTSD, quality of life, and provider assessment.
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Results—Healthcare providers felt the COPS had excellent face validity. Cognitive interviews
revealed that patients’ understanding of the items matched the intended construct, the scale
measured an important concept, and items were easy to understand. The COPS had excellent
internal consistency (alpha=0.9). COPS was negatively associated with age (r=−0.29; p=0.02), but
not with other demographic characteristics. Higher COPS scores were associated with poorer
physical (r=−0.48; p<0.001) and mental (r=−0.39 ; p=0.002 ) health function, quality of life (r=
−0.36; P=0.004) and provider assessment of stability (r=−0.38; p=0.004) as well as with greater
pain grade (r=0.55; p<0.001) and depression (r=0.63; p<0.001). In multivariate analyses, age,
physical and mental health function, and depression were independently associated with COPS.
Conclusions—The COPS has excellent internal consistency and construct validity. Additional
studies are needed to further validate the scale.
Keywords
Chronic pain; quality of life; health function
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Chronic non-malignant pain is an extremely common and challenging problem in primary
care.1 Inadequate assessment of chronic pain has been identified as a key barrier to chronic
pain management.2 Several well-validated instruments exist to measure pain outcomes.3,4
For example, instruments such as the Graded Chronic Pain Scale,5, 6 the Brief Pain
Inventory,7 and the Multidimensional Pain Inventory8 adequately assess pain intensity,
pain-related disability, and interference with activities. Many authors have also suggested
systematically measuring emotional health or co-morbid mental illness in patients with nonmalignant pain3, 4 with measures such as the Beck Depression Inventory9 or the depression
scale of the Patient Health Questionnaire (PHQ-9).10, 11 Moreover, a large number of
instruments exist to measure psychological factors that could potentially influence how a
patient experiences pain. Examples include the Survey of Pain Attitudes (SOPA)12 and
measures of pain catastrophizing.13 However, these measures may not fully capture the
effectiveness of chronic pain management.
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Our clinical experience suggests that it is important to understand how “central” chronic
pain is to a patient’s life: that is, how much pain dominates or “takes over” a patient’s life.
The concept of measuring the “centrality” of pain emerged over several years while the one
of the authors (CN) was supervising a chronic pain practice within an academic internal
medicine clinic. Conversations with patients focused on what was different when their pain
was or was not well controlled. Conversations with primary care providers and chronic pain
specialists focused on what discriminated between patients with good or poor pain control
and what changed when providers were successful in helping patients manage their pain.
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Both patients and providers often felt that current measures of pain intensity, disability, and
interference did not adequately capture what was most important clinically. Furthermore,
while they acknowledged that function was important, they often felt that it was not always
a good measure of the success of pain management, especially in patients with co-morbid
chronic conditions. For example, some patients with very limited function or high pain
severity scores felt that they had good pain control, while others felt their pain was
extremely out of control even though they had fewer functional limitations or rated their
pain severity using a lower number on a 0 to 10 scale. Similarly, patients generally
underscored the importance of how much pain interfered with activities, but they did not feel
it fully captured the impact of pain on their lives. For example, a patient might be able to
continue his or her usual activities, but may feel that pain still dominated his or her thoughts
or life to an unacceptable degree. A key unmeasured element of pain control emerged - how
“central” is the pain to the patient’s life. Both providers and patients often felt that
successful pain control was defined not by reducing the severity of pain, but by reducing the
“centrality” of the pain so that it no longer dominated their thoughts or activities.
Our aim was to develop and psychometrically evaluate an instrument that would measure
the centrality of pain. Such an instrument may be useful both as an outcome measure and as
a clinical tool to guide discussions about goals and expectations for pain management. We
use the term “Centrality of Pain” as a patient-centered concept related to how “central” pain
is to a patient’s life. It is not to be confused with biological phenomenon of pain
centralization, in which normally non-painful stimulation is perceived as pain due to an
alteration in the way such stimuli is processed in the brain and spinal cord.14, 15
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Methods
Setting
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This study was conducted with patients seen in a chronic pain practice within an academic
general internal medicine clinic. The practice was supervised by 2 general internal medicine
attending physicians. Internal medicine residents saw patients in the clinic as part of their
Chronic Illness Management rotation. All of the residents’ patients who were using opioids
for chronic non-malignant pain were assessed at least once in the chronic pain practice.
Faculty could also refer their patients to the practice if they desired additional support in
managing their chronic pain. Patients with complex needs were seen regularly in the chronic
pain practice, while patients with very stable needs were sent back to their primary care
providers for further opioid prescribing. The program kept a registry of primary care patients
on opioids for chronic non-malignant pain. A majority of patients in this practice suffered
from fibromyalgia, chronic back pain, osteoarthritis, chronic abdominal pain, or medically
unexplained chronic pain and had experience pain for over a year.
The Oregon Health & Science University Institutional Review Board approved this study.
We obtained written informed consent from all participants.
Preliminary Scale Development
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The principal investigator (PI) (CN) identified key concepts based on clinical experience
and discussions with patients and colleagues to create a preliminary version of the Centrality
of Pain Scale. She shared early versions of the scale with the members of the Chronic Pain
Interest Group of the Society of General Internal Medicine, as well as with local colleagues
and patients. The scale was revised based on this feedback and included 10 items in the
initial item pool (Table 1.) After the completion of the cognitive interviewing, an expert in
chronic pain management suggested two additional items. The last 47 patients thus
completed a 12 item scale. However, these two items are not included in the final scale as
there was little variation in response to those items and no data on those items from the
cognitive interviews.
Recruitment and data collection

NIH-PA Author Manuscript

All patients presenting to the General Internal Medicine Chronic Pain Clinic over a two
month period were offered a flyer about the study. A co-investigator (TC) approached
patients, described the study, and obtained written informed consent. Participants were
asked to complete the survey, on paper, while in the clinic. After completing the survey, the
first 18 participants also took part in an in-person cognitive interview about the Centrality of
Pain Scale. At the end of the visit, the provider who saw the patient that day in pain clinic
was asked to complete a three-item paper questionnaire about the patient’s pain control.
At the end of this two-month period, we mailed a letter, consent form, and copy of the
survey to all remaining active patients in the chronic pain registry. These patients had been
seen in the chronic pain practice within the past year or had been seen in the chronic pain
practice prior to the last year and were receiving pain management services from their
primary care provider in our general internal medicine clinic. A co-investigator (TC) called
participants who had not returned the mailed survey and reminded them to do so. Once we
received completed surveys and consent forms from participants, we contacted their primary
care providers to ask them to complete the three-item assessment of the patient’s pain
control. Participants were offered $5 for completing the survey and, if applicable, an
additional $5 for participating in a cognitive interview.
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Cognitive interviewing
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We used the technique of cognitive interviewing16 to assess construct validity. Cognitive
interviewing has become a standard method for evaluating the language and clarity of
survey items as well as providing evidence for the content validity of our measure. Testing
survey items with the intended audience can reveal situations where respondents do not have
the information needed to answer a question, where terms used are unclear or ambiguous, or
where respondents’ understanding of an item does not align with the construct the
investigator is trying to capture. Cognitive interviews followed a structured interview guide,
developed under the guidance of a measurement expert (MG). Topics included: 1) whether
or not each item was easy to understand and, if not, how it could be improved; 2) the
participants’ impression of what the scale was trying to measure; 3) examples of what the
participant meant when he or she responded to the items; 4) whether or not the participant
felt the scale was measuring something that was important; 5) whether the items were
measuring one concept or different concepts; and 6) whether there were other important
aspects of pain or pain control that we should be asking about. The co-investigator took
detailed notes during the cognitive interviews and discussed them with the PI.
Construct Validity
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In addition to the new Centrality of Pain Scale, the patient survey included a number of
previously validated measures of constructs that we hypothesized would be associated with
the centrality of pain in patients’ lives. We used the Chronic Graded Pain Scale (CGPS)5, 6
to measure pain intensity and interference, the depression scale of the Patient Health
Questionnaire (PHQ-9)10, 11 to measure depression, the stem questions about generalized
anxiety disorder and panic disorder from the Patient Health Questionnaire17, 18 to screen
for possible anxiety and panic disorders, the Short Form 12 (SF-12)19 to measure physical
and mental health function, the Veterans Administration Post Traumatic Stress Disorder
(PTSD) checklist – civilian version20 to assess PTSD, and a single-item rating quality of life
on a scale of 1 to 10. Patient surveys also included demographic information, items on
lifetime experiences of child abuse, intimate partner violence, and community violence, and
items on satisfaction with the care. Provider surveys asked three items about how well the
patient’s pain was controlled, the stability of the patient’s pain management, and how much
the pain was consuming the patient’s life. Response options for each item were on a 5-point
Likert scale, with higher scores indicating greater pain control, stability of pain
management, and focus on pain in the patient’s life.
Data Analysis
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We used Cronbach’s alpha to assess internal consistency reliability. We calculated the
Centrality of Pain Score by reverse coding items 2, 4, and 9 and totaling the score of all 10
items, so that a higher score corresponds to pain being more central to the patient’s life. To
assess convergent validity, we compared the Centrality of Pain Score to other self-report
measures of pain, mental health, and function described above, as well as to provider’s
assessment of the patient’s pain control. We used Pearson’s Correlation to assess
congruence between COPS and with measures that had continuous scores. We used unpaired
t-tests to assess the association between measures with dichotomous outcomes and COPS
score. We also created a linear regression model with COPS score as the dependent variable.
Independent variables included all available measures of pain, physical, and mental health
outcomes, as well as demographic characteristics found to be associated with COP score at a
level of p < 0.1.

Pain Med. Author manuscript; available in PMC 2012 April 1.

Nicolaidis et al.

Page 5

Results
Participants
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Sixty five of 112 patients (58%) in the chronic pain registry completed the survey. Response
rate was significantly higher for patients who were recruited in person vs. by mail (78% vs.
33%). Mean age was 53 (range 25–77). A majority (65%) were female. As is typical for our
clinic population, the vast majority (82%) were white, non-Hispanic. A majority (62%) were
disabled, with only 19% employed full or part-time and the remainder unemployed (8%) or
retired (12%). Almost all (91%) had completed high school, with 47% also completing
college. A majority (59%) had an annual household income of less than $15,000.
Cognitive Interviewing
We conducted cognitive interviews with the first 18 participants. Participants noted that
items were easy to understand. Participants’ own descriptions of what the items were trying
to measure closely matched the intended construct. They felt that the scale was measuring a
single construct that was extremely important and was not captured well by the other
measures in the survey.
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Based on feedback from 4 participants, we adjusted the wording of one item to increase
clarity. (The phrase “most of the time” was added to the statement “I have control over my
pain”.) The change was felt to be minor, so results are presented together for participants
completing the two versions.
Centrality of Pain Scale
The final Centrality of Pain Scale has 10 items (Table 1). Responses are measured on a 5point Likert Scale with anchors of Strongly Disagree to Strongly Agree. There was adequate
variability in response to all 10 items, with responses ranging from 1 to 5 on each item.
Scale scores are calculated by summing all 10 items and can range from 10 to 50. Scores in
our sample ranged from 13 to 49, with a mean of 31.8, a median of 32, and a standard
deviation of 8.3. The scale showed excellent internal reliability with a Cronbach’s alpha of
0.9. Scores followed a normal distribution without being significantly skewed in either
direction (skewness: - 0.11; std: 0.30).
Construct validity
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Centrality of Pain Score was positively correlated with chronic pain grade (including
chronic pain grade intensity and disability scores and the item on pain interference), severity
of depressive symptoms and provider assessment of how much pain was consuming the
patient’s life.
Centrality of Pain score was negatively correlated with physical health function, mental
health function, quality of life, and provider assessment of pain control. Centrality of pain
score had a slightly weaker association with provider assessment of stability, which did not
reach statistic significance (p=0.08). (Table 2). Patients who screened positive for
depression, PTSD, anxiety or panic disorder had higher Centrality of Pain Scores than
patients who did not (Table 3).
Centrality of Pain score was not associated with gender, race, employment, education, or
income. Centrality of Pain score was negatively associated with age, that is, younger
patients felt that pain was more central to their lives than older patients (r=−0.29; p=0.02).
There was no association between Centrality of Pain score and lifetime experiences with
violence victimization. In multivariate analyses, Centrality of Pain Score was independently
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associated with age, depressive symptoms, and mental and physical health function (Table
4).
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Discussion
The concept of the Centrality of Pain as a measure of patients’ pain control emerged from
years of informal discussions with patients with chronic non-malignant pain, pain experts,
and primary care providers. Theoretically, the patient’s experience of pain can be influenced
by many factors: the underlying physical condition causing the pain, co-morbid physical or
mental health problems, personality traits, attitudes, social stressors, and supports, substance
abuse, lifetime experiences of violence or abuse, and use of medications and other therapies.
The Centrality of Pain Scale is intended to measure the overall effect of these various factors
on the patient’s own perception of how much pain is dominating his or her life. It is not
intended as a judgment about any specific underlying factor contributing to the patient’s
experience of pain.
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Cognitive interviews with primary care patients on opioid therapy for chronic non-malignant
pain confirm that the items in the COPS are easy to understand and that the scale measures a
clear construct that patients feel is important to them and is not well-captured by standard
measures of pain or health function. Preliminary psychometric testing indicates that the scale
has excellent internal consistency and support for construct validity. Patients’ scores on the
Centrality of Pain Scale are correlated in the expected directions with other self-report
measures of pain severity, mental illness, quality of life, physical and mental health function,
as well as with providers’ assessments of pain control. Interestingly, Centrality of Pain
Scores appear to be higher in younger patients than older patients. This result is consistent
with our clinical perception that younger patients with chronic pain often appear to be more
distressed and consumed by pain than their older counterparts, potentially due to a cohort
effect or age-related differences in expectations, roles, and responsibilities.
We recognize this is a preliminary study of a newly defined construct. As such, it has
multiple limitations, including its small size, relatively low response rate, and crosssectional study design. Clearly, other studies will be needed to further assess the reliability
and validity of the COPS. In addition, generalizability may be limited, especially to patients
who are not on chronic opioid therapy, to patients with higher incomes or lower degree of
disability, and to patients from racial or ethnic minority populations.
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However, our study provides important preliminary data supporting the reliability and
validity of an easy to use measure of a construct not included in most pain scales. In our own
clinical experience, we have used the concept of the Centrality of Pain as a basis for clinical
discussions around pain management goals and expectations, as well as to discuss how well
pain management strategies are working. Future studies of the psychometric properties of
the COPS should include exploratory or confirmatory factor analyses to verify the factor
structure of the construct, as well as validating the measure in other populations, and
assessing its test retest reliability and responsiveness to change. Future studies also need to
assess different modalities for administrating the scale, examine its relationship to patient
expectations and outcomes, and its usefulness in clinical practice.
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My pain defines who I am.

I have control over my pain most of the time.**

I think about pain all the time.

My pain consumes all of my energy.

My life revolves around my pain.

Pain is a constant struggle for me.

I can deal with my pain.**

Pain greatly interferes with my life.

3.

4.

5.

6.

7.

8.

9.

10.
31.82

3.60

2.82

3.74

2.95

2.97

2.92

3.25

2.37

8.35

1.13

1.12

1.06

1.33

1.15

1.1

1.19

1.13

1.19

1.15

SD

32

4

3

4

3

3

3

3

2

4

4

Median

13–49

1–5

1–5

1–5

1–5

1–5

1–5

1–5

1–5

1–5

1–5

Range

Reverse scored.

**

All items are rated on a 5-point Likert scale with 1=strongly disagree, 2=disagree, 3=neither agree nor disagree, 4=agree, and 5=strongly agree.

*

I am able to live a full life despite my pain.**

2.

Scale Score

3.74

Pain controls my life.

1.
3.46

Mean

Item*

Please rate how strongly you agree or disagree with each of these statements about your chronic pain on your current pain regimen. Think about how your
pain has affected your life over the past month.

Table 1

NIH-PA Author Manuscript

The Centrality of Pain Scale
Nicolaidis et al.
Page 9

Pain Med. Author manuscript; available in PMC 2012 April 1.

Nicolaidis et al.

Page 10

Table 2

Association between Centrality of Pain Score and measures with continuous outcomes
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Measure

Correlation Coefficient

p-value

Graded Chronic Pain Grade (GCPG)

0.549

<0.001

GCPG – Intensity score

0.499

<0.001

GCPG – Disability score

0.594

<0.001

GCPG – interference item

0.652

<0.001

SF12 Physical Composite Score

−0.483

<0.001

SF12 Mental Composite Score

−0.385

0.002

PHQ 9 (depressive symptoms)

0.627

<0.001

Quality of Life

−0.357

0.004

Provider assessment of pain control

−0.418

0.002

Provider assessment of stability of pain management

−0.244

0.078

Provider assessment of how much pain is consuming patient’s life

0.399

0.003

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Pain Med. Author manuscript; available in PMC 2012 April 1.

NIH-PA Author Manuscript

NIH-PA Author Manuscript

PTSD

Panic

45
16

Yes

25

Yes

No

36

41

Yes

No

20

No

25

>=10

Anxiety

38

<10

PHQ9

N

Groups

Measure

36.7

29.9

36.4

28.4

34.7

25.6

36.6

28.8

Mean COP
score

8.47

7.90

7.16

7.91

7.08

8.06

8.33

7.04

SD

−2.88

−4.03

0.12

0.22

0.26

0.21

−4.01

−4.52

Effect
Size

T-value

0.005

0.0002

0.0002

<0.0001

P value

Association between Centrality of Pain Score and measures with dichotomous outcomes
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Table 4

Independent associations with Centrality of Pain Score
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Independent Variable*

Beta

P-value

Age (continuous)

−0.228

0.039

PHQ-9

0.402

0.007

SF12 – PCS

−0.415

0.002

SF12- MCS

−0.341

0.022

Pain Grade

0.224

0.070

Panic

0.203

0.080

PTSD

−0.217

0.089

*

Also adjusted for quality of life, anxiety, and provider assessment score, none of which were statistically significant, p>0.4.
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